User profiles for Carlo B. Bifulco
 | Carlo BifulcoProvidence Verified email at providence.org Cited by 5783 |
[HTML][HTML] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck …
EEW Cohen, RB Bell, CB Bifulco, B Burtness… - … for immunotherapy of …, 2019 - Springer
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …
sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and …
[HTML][HTML] The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and …
…, K Von Loga, II Wistuba, CB Bifulco - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Objectives The interaction between the immune system and tumor cells is an important feature
for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and …
for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and …
[PDF][PDF] Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers
Tumor-infiltrating neoantigen-reactive T cells can mediate regression of metastatic
gastrointestinal cancers yet remain poorly characterized. We performed immunological screening …
gastrointestinal cancers yet remain poorly characterized. We performed immunological screening …
[HTML][HTML] Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor …
…, SC Chang, Y Koguchi, CB Bifulco, B Bernard… - Nature …, 2021 - nature.com
Despite the success of checkpoint blockade in some cancer patients, there is an unmet need
to improve outcomes. Targeting alternative pathways, such as costimulatory molecules (eg …
to improve outcomes. Targeting alternative pathways, such as costimulatory molecules (eg …
[HTML][HTML] Multiparametric immune profiling in HPV–oral squamous cell cancer
…, CB Bifulco, J Bukur, C Wickenhauser, B Seliger… - JCI insight, 2017 - ncbi.nlm.nih.gov
Abstract Evaluation of T lymphocyte frequency provides prognostic information for patients
with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T …
with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T …
[HTML][HTML] Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
…, C Wang, WJ Urba, BD Curti, CB Bifulco… - … for immunotherapy of …, 2015 - Springer
Background Adoptive T cell therapy (ACT) has shown great promise in melanoma, with over
50 % response rate in patients where autologous tumor-reactive tumor-infiltrating …
50 % response rate in patients where autologous tumor-reactive tumor-infiltrating …
[HTML][HTML] The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
Recent investigations of the tumor microenvironment have shown that many tumors are
infiltrated by inflammatory and lymphocytic cells. Increasing evidence suggests that the number, …
infiltrated by inflammatory and lymphocytic cells. Increasing evidence suggests that the number, …
Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity
…, K Wegmann, S Jensen, J Jin, CB Bifulco… - Journal of clinical and …, 2021 - cambridge.org
Introduction:The COVID-19 pandemic has created a high demand on personal protective
equipment, including disposable N95 masks. Given the need for mask reuse, we tested the …
equipment, including disposable N95 masks. Given the need for mask reuse, we tested the …
[HTML][HTML] Multispectral imaging of T and B cells in murine spleen and tumor
…, M Farhad, M Neuberger, CB Bifulco… - The Journal of …, 2016 - journals.aai.org
Recent advances in multiplex immunohistochemistry techniques allow for quantitative,
spatial identification of multiple immune parameters for enhanced diagnostic and prognostic …
spatial identification of multiple immune parameters for enhanced diagnostic and prognostic …
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 …
…, CR Acharya, K Zablotsky, BA Fox, CB Bifulco… - Clinical Cancer …, 2021 - AACR
Purpose: Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic
options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD…
options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD…
